Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure

[1]  S. Lehmann,et al.  Selenite is a potent cytotoxic agent for human primary AML cells. , 2009, Cancer Letters.

[2]  R. Zhao,et al.  Effects of Selenite and Genistein on G2/M Cell Cycle Arrest and Apoptosis in Human Prostate Cancer Cells , 2009, Nutrition and cancer.

[3]  Y. Shang,et al.  Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. , 2009, Free radical biology & medicine.

[4]  M. Ahmed,et al.  High-Dose Sodium Selenite Can Induce Apoptosis of Lymphoma Cells in Adult Patients with Non-Hodgkin’s Lymphoma , 2009, Biological Trace Element Research.

[5]  M. Bosland,et al.  Differential Effects of Selenium on Benign and Malignant Prostate Epithelial Cells: Stimulation of LNCaP Cell Growth by Noncytotoxic, Low Selenite Concentrations , 2009, Nutrition and cancer.

[6]  Jian Li,et al.  Exposure of human leukemia NB4 cells to increasing concentrations of selenite switches the signaling from pro-survival to pro-apoptosis , 2009, Annals of Hematology.

[7]  F. Lang,et al.  Suicidal Death of Erythrocytes Due to Selenium-Compounds , 2008, Cellular Physiology and Biochemistry.

[8]  Yang Yang,et al.  P53 transcription-independent activity mediates selenite-induced acute promyelocytic leukemia NB4 cell apoptosis. , 2008, BMB reports.

[9]  M. Červinka,et al.  Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells , 2008, Cell Biology and Toxicology.

[10]  K. O'Byrne,et al.  Advances in the systemic therapy of malignant pleural mesothelioma , 2008, Nature Clinical Practice Oncology.

[11]  A. Hjerpe,et al.  Targeted Therapy—Possible New Therapeutic Option for Malignant Mesothelioma? , 2008, Connective tissue research.

[12]  Eun Hee Kim,et al.  Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. , 2007, Cancer research.

[13]  J. Nesland,et al.  Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma. , 2007, Human pathology.

[14]  K. V. Donkena,et al.  Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[15]  G. Gordon,et al.  Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma , 2007, The Journal of pathology.

[16]  G. Nilsonne,et al.  Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells. , 2007, Differentiation; research in biological diversity.

[17]  G. Nilsonne,et al.  Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress. , 2006, Free radical biology & medicine.

[18]  D. Feldman,et al.  Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action , 2006, Molecular Cancer Therapeutics.

[19]  A. Davies,et al.  The Use of Chemotherapy in Patients with Advanced Malignant Pleural Mesothelioma: A Systematic Review and Practice Guideline , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  Cheng Jiang,et al.  Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway , 2006, Molecular Cancer Therapeutics.

[21]  A. Olshen,et al.  Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. , 2006, Cancer research.

[22]  R. Zhao,et al.  Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. , 2006, Cancer research.

[23]  D. Peehl,et al.  Tumor‐selective killing by selenite in patient‐matched pairs of normal and malignant prostate cells , 2006, The Prostate.

[24]  T. Welte,et al.  Cathepsin-regulated apoptosis , 2006, Apoptosis.

[25]  D. Burstein,et al.  Immunocytochemical detection of XIAP in body cavity effusions and washes , 2005, Modern Pathology.

[26]  K. Dahlman-Wright,et al.  Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling , 2005, The Journal of pathology.

[27]  P. Hainaut,et al.  Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity , 2005, Oncogene.

[28]  David J Sugarbaker,et al.  Tumorigenesis and Neoplastic Progression Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling , 2005 .

[29]  W. Korohoda,et al.  Differential effects of selenite and selenate on human melanocytes, keratinocytes, and melanoma cells. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[30]  M. Stoltenberg,et al.  Zinc-specific Autometallographic In Vivo Selenium Methods: Tracing of Zinc-enriched (ZEN) Terminals, ZEN Pathways, and Pools of Zinc Ions in a Multitude of Other ZEN Cells , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  Cheng Jiang,et al.  Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. , 2004, Molecular cancer therapeutics.

[32]  D. Fennell,et al.  Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. , 2004, The Lancet. Oncology.

[33]  A. Rosén,et al.  Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. , 2004, Biochemical pharmacology.

[34]  Taesoo Kim,et al.  Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide. , 2003, Biochemical pharmacology.

[35]  O. Tirosh,et al.  Selenite activates caspase-independent necrotic cell death in Jurkat T cells and J774.2 macrophages by affecting mitochondrial oxidant generation. , 2003, Antioxidants & redox signaling.

[36]  K. Krejcy,et al.  Chemotherapy for malignant pleural mesothelioma: past results and recent developments , 2003, British Journal of Cancer.

[37]  E. Muller,et al.  Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione. , 2002, Carcinogenesis.

[38]  Cheng Jiang,et al.  Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. , 2002, Molecular cancer therapeutics.

[39]  K. Wiman,et al.  A Novel High-Through-Put Assay for Screening of Pro-Apoptotic Drugs , 2002, Investigational New Drugs.

[40]  G. Gordon,et al.  Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. , 2002, Carcinogenesis.

[41]  G. Melloni,et al.  Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. , 2001, Lung cancer.

[42]  Elias S. J. Arnér,et al.  The Core Promoter of Human Thioredoxin Reductase 1 , 2001, The Journal of Biological Chemistry.

[43]  X. Sun,et al.  Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells. , 2000, Differentiation; research in biological diversity.

[44]  Elias S. J. Arnér,et al.  Truncated Thioredoxin Is a Mitogenic Cytokine for Resting Human Peripheral Blood Mononuclear Cells and Is Present in Human Plasma* , 2000, The Journal of Biological Chemistry.

[45]  K R Abrams,et al.  Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems , 2000, Thorax.

[46]  T. Sakai,et al.  Thioredoxin-dependent Redox Regulation of p53-mediated p21 Activation* , 1999, The Journal of Biological Chemistry.

[47]  Y. Soini,et al.  Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  G. D. Pearson,et al.  The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase. , 1999, Cancer research.

[49]  C. Ong,et al.  Sodium selenite‐induced oxidative stress and apoptosis in human hepatoma HepG2 cells , 1999, International journal of cancer.

[50]  B. Persson,et al.  Immunocytochemical detection and mapping of a cytokeratin 18 neo‐epitope exposed during early apoptosis , 1999, The Journal of pathology.

[51]  A. Gartel,et al.  Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.

[52]  P. Hainaut,et al.  Modulation of p53 protein conformation and DNA‐binding activity by intracellular chelation of zinc , 1998, Molecular carcinogenesis.

[53]  J. Herndon,et al.  Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. , 1998, Chest.

[54]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Holmgren,et al.  Selenite and selenate inhibit human lymphocyte growth via different mechanisms. , 1996, Cancer research.

[56]  Cheng Jiang,et al.  Dissociation of the genotoxic and growth inhibitory effects of selenium. , 1995, Biochemical pharmacology.

[57]  P. Hainaut,et al.  Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. , 1993, Cancer research.

[58]  L. Yan,et al.  Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. , 1993, Biochemical pharmacology.

[59]  G. Gahrton,et al.  Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. , 1989, Cancer research.

[60]  R. Zhao,et al.  Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells , 2008, Cancer Chemotherapy and Pharmacology.

[61]  C. Ong,et al.  Superoxide radical-initiated apoptotic signalling pathway in selenite-treated HepG(2) cells: mitochondria serve as the main target. , 2001, Free radical biology & medicine.